Global Trend
Startup answering ‘final 3%’ question becomes big pharma R&D engine
On December 11 last year, an employee conducts a virus experiment at the laboratory of Apriori Bio in Somerville, Massachusetts, United States. Here, ultra-high-priced experimental equipment that ordinary startups can hardly afford is shared, and experts gather for active idea discussions. Somervill
2026.01.12